Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INDOOR: Dolutegravir Switch for HIV Reservoir Dynamics
NCT02513147Phase 4Completed
- Sponsor
- Vall d'Hebron Research Institute
- Start
- Jun 2015
- Primary completion
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dolutegravir in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Vall d'Hebron Research Institute. Started Jun 2015; status: completed.
02
Drugs
dolutegravir
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT02513147.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02513147.